Welcome to our dedicated page for Axcelis Technologies news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Technologies stock.
Axcelis Technologies Inc. (Nasdaq: ACLS) is a world-leading provider of equipment and services to the semiconductor manufacturing industry. For over 35 years, Axcelis has been a trusted partner for chipmakers globally, delivering cutting-edge solutions and expertise in the critical process of ion implantation. This process is essential for the fabrication of semiconductor chips used in everyday electronics such as smartphones, laptops, cameras, and more.
The company's suite of products includes advanced ion implantation systems, which form transistors that power electronic devices. Axcelis' Purion™ platform is renowned for its flexibility and advanced technology, catering to diverse needs from high current to high energy implants. The Purion Power Series™, particularly, addresses the growing demand in power device applications, including silicon carbide (SiC) technology, crucial for automotive, industrial, and energy applications.
Axcelis also offers comprehensive aftermarket services, including spare parts, equipment upgrades, maintenance, and customer training, ensuring maximum operational efficiency and longevity of its products. The company’s advanced technology center in Beverly, Mass., serves as a hub for innovation, collaborating with industry experts and customers to develop next-generation applications.
Financially robust, Axcelis continues to achieve record performance. In 2023, the company reported a 23% year-over-year growth, with revenues surpassing $1.1 billion. The strong market position is further evidenced by a $1.2 billion backlog at the year's end. Axcelis' strategic focus on the Asia Pacific region, which contributes significantly to its revenue, underscores its global outreach and market adaptability.
Recent achievements highlight Axcelis' leadership and innovation. The company showcased its latest technologies at SEMICON Korea 2024 and announced multiple shipments of its Purion Power Series™ to leading chipmakers worldwide. Axcelis also strengthened its board with new directors, bringing in valuable industry expertise.
As the semiconductor industry evolves, Axcelis remains committed to driving innovation and supporting its customers with state-of-the-art ion implantation solutions, ensuring a bright and technologically advanced future.
Axcelis Technologies (Nasdaq: ACLS) will release its Q4 and FY 2021 financial results on February 7, 2022, at 4:00 p.m. ET. A conference call to discuss the results will follow at 5:00 p.m. ET, accessible via an audio webcast on the Axcelis website. Interested investors can dial in using 866.588.8911 (or 707.294.1561 internationally). Axcelis, based in Beverly, Mass., specializes in ion implantation systems for the semiconductor industry.
Axcelis Technologies (Nasdaq: ACLS) announced the shipment of multiple Purion M medium current implanters and a new evaluation tool to memory device makers. These shipments occurred in Q4 2021 and Q1 2022, showcasing strong demand for the Purion M platform. Executive VP Bill Bintz highlighted the platform's flexibility and continued strength in the memory and mature process technology markets as key growth drivers for 2022.
Axcelis Technologies (Nasdaq: ACLS) announced follow-on shipments of the Purion H200 SiC Power Series™ high current implanters to a major power device chipmaker in Asia and Europe during Q3 and Q4. Additionally, the company closed a Purion XE Power Series SiC high energy implanter evaluation for a new European customer. These systems will aid in high-volume production of SiC power devices for the automotive market. The SiC power device market is projected to grow at a 30% CAGR from 2019 to 2025, indicating strong demand for advanced semiconductor solutions.
Axcelis Technologies (Nasdaq: ACLS) announced its participation in the 24th Annual Needham Virtual Growth Conference from January 10-14, 2022. Key executives, including Mary Puma and Kevin Brewer, will host a fireside chat on January 11 at 1:15 p.m. EST, with one-on-one meetings available. A live webcast of the presentation will be accessible via Axcelis' website and will be available for replay for 30 days post-event. This engagement highlights Axcelis' ongoing contributions to the semiconductor industry.
Axcelis Technologies, Inc. (Nasdaq: ACLS) has successfully completed a Purion H™ high current tool evaluation at a top advanced logic device manufacturer. This evaluation is expected to boost high-volume production capabilities for advanced logic devices. Bill Bintz, Executive VP of Product Development, emphasized the positive outlook for 2022 and 2023, citing opportunities for production buys. The Purion H features cutting-edge scanned spot beam technology that enhances device performance and yield while maintaining low operational costs.
Axcelis Technologies (NASDAQ: ACLS) announced its participation in the 10th Annual December CEO Summit on December 8, 2021, in San Francisco, CA. This event coincides with SEMICON West 2021 and involves small group meetings with 11 other companies, including ACM Research and Aehr Test. Attendance is by invitation only for accredited investors and research analysts, with a registration deadline of November 29. Presentation materials will be available on Axcelis' investor page. Proof of COVID vaccination is required for in-person attendees.
Axcelis Technologies (Nasdaq: ACLS) announced a Virtual Investor Day scheduled for December 9, 2021, from 12:00 p.m. ET to 2:00 p.m. ET. The event aims to engage the investment community and will feature presentations from the company's executive team focusing on future growth opportunities, followed by a Q&A session. All executive officers are expected to attend the event. For registration and more details, participants can visit investorday.axcelis.com. An archived version of the webcast will also be available post-event.
Axcelis Technologies (Nasdaq: ACLS) announced its participation in the SEMICON Japan 2021 exhibition, set for December 15-17 in Tokyo. The company will showcase its Purion™ and GSD Ovation™ Series of ion implanters at Booth #5731. The Purion Series is noted for its high purity and precision across various applications, while the GSD Ovation Series is designed for 200mm fab construction. CEO Mary Puma highlighted the importance of introducing advanced ion implant technologies to Japanese chipmakers to meet the growing demand in power devices and memory markets.
Axcelis Technologies (NASDAQ: ACLS), a leading supplier in the semiconductor sector, announced its participation in various investor conferences in November and December 2021. Key events include the Benchmark Company Technology Virtual Video 1x1 Investor Conference on November 17, the CEO Summit 2021 in San Francisco on December 8, the 2021 Virtual Investor Day on December 9, and the DA Davidson Semicap, Laser, and Optical Conference on December 15. These conferences provide a platform for management to engage with investors through virtual one-on-ones.
Axcelis Technologies, Inc. (Nasdaq: ACLS) reported strong financial results for Q3 2021, achieving revenue of $176.7 million, up from $147.3 million in Q2. The record system revenue of $126.2 million reflects growth in the implant systems segment. Net income rose to $27.5 million or $0.81 per diluted share, compared to $18.9 million or $0.55 in the previous quarter. The company anticipates approximately $190 million in revenue for Q4, with a gross margin expectation of 41.5%.